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Abstract 
 
The analgesic and antipyretic properties of paracetamol were first described in 1893, then it has been widely available as a 
non-prescription drug, with a therapeutic profile that reflects widespread safety and efficacy as well as paracetamol became the 
most widely used analgesic and antipyretic in children. It is the most frequently used over-the counter medicine in young 
children and is nearly universally used in infants. The drug is used by millions of children every day. The study was designed 
to study the toxicological effect of therapeutic dose of paracetamol after oral administration for three months in laboratory rats 
(Rattus norvegicous) on the heart, kidney and liver. Results showed oral administration of the paracetamol for three months in 
laboratory rats showed that this drug has a severe damaging effect on most of the vital organs in the body like kidney, liver and 
heart.  
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ل￿￿￿￿￿￿ار￿￿￿ا تا￿￿￿￿￿    ￿￿￿￿ط ة￿￿￿ ￿￿￿￿￿ا   
،￿￿￿￿ ￿ظ￿￿ ￿￿￿    ￿￿￿!￿ا ￿￿" ￿￿#￿    و ن￿&￿ر م￿￿و   ر()￿  
  
￿￿￿￿   ￿￿￿ا   ي￿￿￿￿￿ا ،   ￿￿￿￿  ،ة￿￿￿￿ا ،ة￿￿￿￿ا ￿ قا￿￿￿ا  
  
￿ *#￿ا   
 
 م￿￿ ￿￿ ￿￿￿￿و ￿￿ ةرا￿ ￿￿ ￿!￿￿"￿ا و ￿#$￿%￿ا صا'"￿￿ (￿و لوا نا ١٨٩٣    /01 ا￿20 34او 5678 ج:￿￿ /￿ا$";4ا ￿￿ <￿ذ ه$￿8
و ى$￿ ￿￿ظا ￿￿%A￿ا ￿￿B C￿ 34ا  , ￿￿ ةرا￿ ￿￿ ￿2￿￿D و ￿#$￿￿ ةد￿%￿ 34او 5678 ر￿F￿￿ا م$";4ا <￿G￿   ل￿￿ط1ا  .  C￿8 ج:￿￿ م$";AI <￿G￿
ةد1'￿ا ￿JI$Kو C￿￿￿￿￿￿ا  . م$";AI <￿G￿و   م'I 5￿ ￿￿ ل￿￿ط1ا C￿I:￿ 5￿B C￿ .    هGھ M%%￿ ￿4ار$￿ا    ￿￿￿￿%￿  ￿￿￿:￿￿ا ￿￿￿N￿￿ ￿%A￿ا ￿￿O￿;￿ا
￿ا ل'￿￿;￿4ا￿￿￿ا ر￿F￿￿ ￿I￿￿;"%￿ا ناذ￿N￿ا ￿￿ ￿￿￿6￿او $￿6￿او ￿￿F￿ا 5J￿ ء￿!￿1ا Q￿8 R￿￿￿￿I'ط ة￿;￿￿و ￿￿￿ا SI￿ط C￿ ة￿￿￿%  .  ت￿￿ظا
 نا U#￿;V￿ا ￿F￿ا 5J￿ ￿AN￿ا ￿￿ ￿%￿%￿ا ء￿!￿1ا C￿ ￿￿J￿ R￿￿ ةر￿W تا￿￿O￿￿ ￿￿Xا ￿O:O ة$%￿ ل'￿￿;￿4ا￿￿￿ا ر￿F￿￿ ي'%￿￿ا 3I￿N;￿ا ￿    ￿￿￿6￿او
$￿6￿او .  
  
 
Introduction 
 
Paracetamol (known as acetaminophen in the United 
States) is one of the most commonly used nonsteroidal anti-
inflammatory drugs (NSAIDs) (1). It is a rapid, reversible, 
noncompetitive inhibitor of cyclooxygenase activity and 
thus  products  of  the  arachidonic  acid 
cascade,.acetaminophen has been available since the 1950s 
as an over-the-counter product for pain and fever relief. 
Acetaminophen has long been recognized as  potentially 
lethal because of  dose-related hepatic,  and often  renal, 
injury  (1,2).  Although  its  metabolism  is  quite  well 
understood,  the  mechanism  of  acetaminophen  toxicity 
remains  somewhat  a  mystery  with  recent  evidence 
suggesting that multiple cytotoxic pathways are involved 
(3). Historically, alcohol use was claimed as an important 
risk factor, with the accidental nature of acetaminophen 
toxicity  in  alcoholics  being  termed  a  ‘therapeutic 
misadventure (3,4). Metabolic synergy between alcohol and 
acetaminophen appears to enhance the toxic reaction but 
how important this is clinically remains a matter of debate 
(5,6). Low dose ingestions having harmful consequences 
appear to be more likely in association with alcohol use (7). 
Prior to the 1990s, only  a few cases of  acetaminophen Iraqi Journal of Veterinary Sciences, Vol. 27, No. 1, 2013 (65-70) 
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poisoning had been reported; acetaminophen toxicity was 
not listed at all in transplant series until two reports in the 
late 1990’s.  The  Acute  Liver  Failure  Study  Group  has 
compiled data on more than 500 acetaminophen-related 
ALF cases showing that the number of cases has increased 
considerably  since  1998  (8).  Suicidal  overdose  of 
acetaminophen is the most frequent form of liver injury in 
the United Kingdom (7). Most people who attempt suicide 
admit to the misdeed and seek help early. 
Most people are only at risk for liver toxicity if they 
take  more  than  the  normal  recommended  amount  of 
acetaminophen. Most cases of liver damage occur in people 
who have taken at least 10-15 grams—more than twice the 
recommended dose. Many of the emergency room visits 
and deaths linked to acetaminophen poisoning are due to 
accidental or intentional overdoses. But some people are 
more  susceptible  to  acetaminophen  toxicity  and  can 
experience liver damage even at the recommended dose. A 
study by the U.S. Food and Drug Administration (FDA) 
showed that about  20% of  people with  acetaminophen-
related liver toxicity had taken less than the recommended 
daily amount. For other people, a dangerous dose is not 
much higher  than  the recommended  dose—that  is,  the 
“window” between a therapeutic dose and a toxic dose is 
smaller for acetaminophen than it is for many other drugs. 
Some experts also believe that taking acetaminophen for 
several days in a row may cause a dangerous build-up of 
the drug in the body (9). 
Paracetamol also has direct actions on the kidney (10). 
demonstrated  that  in  the  isolated  perfused  rat  kidney, 
administration of paracetamol resulted in a decrease in GFR 
and PGE2. Similarly, in normal human volunteers treated 
with paracetamol for 3 days, a reduction in urinary PGE2 
and  sodium  excretion  was  observed.  In  addition, 
paracetamol induced a delay in the onset of diuresis after an 
acute water load (4). Paracetamol also exerts acute and 
chronic nephrotoxic effects. Acute ingestion of large doses 
(10–15 g) is characterized by necrosis and damage to the 
proximal  tubule.  However,  it  is  recognized  from  both 
clinical and experimental studies that much lower doses 
(500–1000 mg) can produce renal damage, especially in 
patients  with  hepatic  disease  or  those  taking  enzyme 
inducer drugs (carabamazepine and phenytoin) or in the 
malnourished (2). Chronic ingestion of paracetamol results 
in  analgesic  nephropathy.  This  is  defined  as  habitual 
ingestion of an analgesic, which after an insidious onset, 
leads to  renal papillary  necrosis and  chronic  interstitial 
nephritis with progressive renal failure (6). Epidemiological 
studies  show  that  longterm  regular  consumption  of 
paracetamol increases the relative  risk of chronic  renal 
disease to 3.2 (3), whereas the odds ratio for end stage renal 
disease  was  2.1  for  the  heaviest  annual  intake  of 
paracetamol and 2.4 for cumulative lifetime intake of more 
than 5000 tablets containing paracetamol (7). In the present 
study  we  report  the  long-term  (90  days)  toxicological 
effects of paracetamol in rats. 
 
Materials and methods 
 
Twenty four Rattus norvegicus rats were selected for 
this experiment and housed in normal photoperiod regime 
in  the  laboratory  for  two  weeks  to  give  a  chance  for 
acclimatization and for anti-bacterial and anti-parasitic drug 
administration. Animals were divided  in to four  groups, 
control group, low dose treated group, intermediate dose 
treated group  and high  dose  treated group,  each  group 
consist of six animals. Animals of the control group were 
given normal physiological saline, the group of low dose, 
intermediate  dose  and  high  dose  treated  with 
acetanimophen orally as 250 mg/ kg, 500 mg/kg, and 1000 
mg/ kg respectively daily for three months. The animals of 
all groups were killed at the end of the experiment and the 
organs (liver,  kidney and  heart) fixed  in 10%  buffered 
formalin and sent to laboratory for sectioning at 5 µm and 
stained with hematoxylin and eosin. 
 
Results 
 
The liver, kidney and heart of the control group were 
showed normal histological structure (Fig 1-3).  
In the group of low dose the liver showed congestion, 
minimal  fibrosis  in  the  periportal  area and  degenerative 
changes  in  the  hepatocytes  with  severe  infiltration  of 
inflammatory cells in the subcapsular region (Fig 4). The 
kidney showed degeneration in the renal tubular epithelium 
in the cortical region (Fig 5), while in the heart there were 
moderate vacuolation in the myocardial muscle cells (Fig 
6).  
In the group of intermediate dose the liver showed more 
massive fibrosis with severe fatty degeneration of the which 
indicated by presence of clear vacuoles in the cytoplasm of 
the  hepatocytes  (Fig  7),  the  kidney  showed  glumerular 
atrophy  with  degenerative  changes  in  the  renal  tubular 
epithelium (Fig 8), in the heart there is marked vacoulation 
in the myocardial muscle cells (Fig 9).  
In the group of high dose the liver revealed vacuolation 
of  hepatocytes  with  congestion  of  the  central  vein  and 
marked  fibrosis  in  the  periportal area  with  hepatocellular 
necrosis in the central area and the subcapsular region (Fig 
10,11), in the kidney there were degeneration of medulary 
renal tubular epithelium as well as there were hemorrhage 
in the glumeruli with glumeriolar atrophy (Fig 12,13), in 
the heart there were severe vacoulation in the myocardial 
muscle  fibers  as  well as  the  severe atrophy and fibrosis 
specially in the pericardial region (Fig 14,15). 
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Fig 1: Normal  microscopic structure of  the liver  which 
shows normal hepatocytes in centrilobular are. H&E 125X. 
 
 
 
Fig  2:  Normal  microscopic  appearance  of  the  kidney 
reveale A) the normal glomeruli B) Normal renal tubules in 
the cortical area.H&E 125X. 
 
 
 
Fig 3: Normal microscopic appearance of the myocardium 
H&E 125X. 
 
 
Fig 4: Microscopic appearance of the liver in the group of 
low dose showes A) conjestion with minimal fibrosis in the 
periportal area  B)  infiltration  of  inflammatory  cells  in 
subcapsular area H&E 125X. 
 
 
 
Fig  5:  Kidney  of  low  dose  group  reveal  A)  slightly 
atrophied  glomerulus  B)  degeneration  of  renal  tubular 
epithelium H&E 125X. 
 
 
 
Fig 6: Myocardial muscle of the low dose treated group 
showes minimal  vacoulation of  the myocardial  muscle 
cells. H&E 125X. Iraqi Journal of Veterinary Sciences, Vol. 27, No. 1, 2013 (65-70) 
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Fig 7: Liver of inter mediate dose treated group shows A) 
moderate  fibrosis  in  the  periportal  area  B)  massive 
vacoulation of the hepatocytes H&E 125X. 
 
 
 
Fig 8:  Kidney  of  intermediate treated  group  shows  A) 
marked atrophied glomeruli B) degeneration of the renal 
tubular epithelium H&E 125X. 
 
 
 
Fig 9: Heart  of intermediate treated  group shows  sever 
atrophied myocardial muscle cells H&E 125X. 
 
 
 
Fig 10: Liver of high dose treated group reveal necrotic 
change of the hepatocytes in the centrilobular area H&E 
125X. 
 
 
 
Fig 11: Liver of high dose treated group reveal necrotic 
change of the hepatocytes in subcapsular area H&E 125X. 
 
 
 
Fig 12:  Medullary region  of the  kidney reveal  massive 
degenerative change in the renal tubular epithelium H&E 
125X. 
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Fig 13: Kidney of the high dose treated group reveal A) 
glomerular atrophy and hemorrhage B) degeneration of 
renal tubular epithelium H&E 125X. 
 
 
 
Fig 14: Heart of high dose treated group reveal atrophy of 
the myocardial muscle cells with fibrosis in endocardial 
region H&E 125X. 
 
 
 
Fig 15: Heart of high dose treated group reveal atrophy of 
the myocardial muscle cells with fibrosis in endocardial 
region H&E 125X. 
 
Disscusion 
 
Paracetamol is one of the most common antipyretic and 
analgesic used all over the world. It is easily accessible over 
the counter and thus intentional paracetamol overdose is 
common. Ingestion of more than 12.5 g or 25 tablets  is 
associated with acute liver dysfunction. 
The renal tubular changes which has been found in this 
research was agreed with results of other researches which 
found that The paracetamol induced renal damage results 
from a mechanism similar to that which is responsible for 
hepatotoxicity(8,11).  Renal  failure  secondary  to  acute 
tubular necrosis  occurs  in  25% of  patients  with  severe 
hepatic damage and this result agreed with the result of this 
research in which most of the animals showed damages in 
both kidneys and livers and in a few without evidence of 
serious disturbance of liver function. 
The  pathophysiological  mechanism  of  paracetamol 
poisoning is well known. Normally the acetaminophen is 
mainly metabolised to non-toxic metabolites that are renally 
excreted. However,  in overdose  situation, the  non-toxic 
metabolic pathways are saturated and more paracetamol 
will  go  through  metabolism  by  the  cytochrome  P450 
pathway,  resulting  in  the  accumulation  of  the  toxic 
metabolite N-acetyl-pbenzoquinoneimine (NAPQI). The 
NAPQI  is  detoxified  by  glutathione  until  the  store  is 
depleted. The NAPQI will then bind to cellular  proteins 
causing damage and cell death (12).  
Paracetamol is rapidly absorbed from the small intestine 
and has a high bioavailability of around 80% after first-pass 
metabolism. The pathophysiology of paracetamol poisoning 
is  closely  related  to  its  metabolism.  Paracetamol  is 
predominantly metabolised in the liver by conjugation with 
sulphate (around 30%) and glucuronide (60%). A smaller 
amount  is  eliminated  unchanged  in  urine.  However, 
approximately 5e10% of paracetamol is metabolised to N-
acetyl-P-benzoquinoneimine (NAPQI), a toxic metabolite 
via  CYP450-dependent  pathways.  NAPQI  is  then 
detoxified by glutathione and is eliminated in urine or bile. 
At toxic levels, sulphate and glucuronide conjugation can 
be saturated. This leads to glutathione depletion as more 
paracetamol is metabolised through the CYP450 pathways, 
and NAPQI may accumulate. NAPQI that is not detoxified 
then reacts  with sulphydryl  groups on  hepatocytes  and 
causes hepatocellular  necrosis and  this agreed  with  the 
result of the present study. In infants and young children, 
the dominant pathway of metabolism appears to be sulphate 
conjugation while glucuronide conjugation matures slowly. 
Children are also thought to have a more active oxidative 
pathway,  resulting  in  an  increased  rate  of  glutathione 
production, thereby conferring a protective effect  from 
hepatotoxicity in young children. The greater capacity for 
sulphation  in  young  children  alongside  an  increased 
incidence of vomiting may also explain why young children Iraqi Journal of Veterinary Sciences, Vol. 27, No. 1, 2013 (65-70) 
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appear  less  susceptible  to  hepatotoxicity  compared  to 
adults.  Despite  these  apparent  protective  mechanisms 
paracetamol may accumulate significantly in children after 
repeated therapeutic doses. Although no children developed 
hepatotoxicity  after  repeated  doses  of  between  66e81 
mg/kg/day,  increases  in  AUC  of  14e33%  were  seen. 
Significant accumulation may explain why children who 
had ingested multiple supratherapeutic overdoses appear to 
have worse outcomes (13). 
Most of the cardiac muscle change result not from direct 
effect of paracetamol but could result from the damage of 
the kidney which cause fluid retention then hypertension 
and the cardiac damage occur as a consequence for increase 
blood pressure but we did not find any research to support 
this result. 
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